4//SEC Filing
RAVICH MARK H 4
Accession 0001628279-20-000218
CIK 0001041024other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 7:07 PM ET
Size
17.4 KB
Accession
0001628279-20-000218
Insider Transaction Report
Form 4
RAVICH MARK H
Director
Transactions
- Other
Common Stock
2020-09-03$1.22/sh+194,905$237,784→ 194,905 total(indirect: By Trust) - Other
Common Stock
2020-09-04$1.16/sh−9,000$10,440→ 16,000 total(indirect: By Trust) - Other
Common Stock
2020-09-04$1.22/sh+25,000$30,500→ 219,905 total(indirect: By Trust) - Other
Common Stock
2020-09-03$1.21/sh−11,000$13,310→ 0 total(indirect: By Trust) - Other
Common Stock
2020-09-04$1.16/sh−16,000$18,560→ 9,000 total(indirect: By Trust) - Other
Common Stock
2020-09-03$1.21/sh−173,905$210,425→ 213,604 total - Other
Common Stock
2020-09-04$1.16/sh−10,000$11,600→ 203,604 total
Footnotes (10)
- [F1]Represents the transfer of shares of common stock to Cindy Libman Irrevocable Trust ("CL Trust") for which the Reporting Person is the trustee. The Reporting Person's total beneficial ownership in the Issuer has not changed, as he was the beneficial owner of these shares both before and after the transfers reported herein.
- [F10]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range.
- [F3]Includes 30,000 shares of common stock underlying unvested restricted stock units that vest based on the achievement of certain time-based milestones.
- [F4]Includes 1,000 shares which were inadvertently omitted in previous filings due to administrative error.
- [F5]Represents securities owned directly by Norman and Sally Ravich Family Trust ("NSR Trust"). Mr. Ravich, as the trustee of NSR Trust, may be deemed to beneficially own the securities owned directly by NSR Trust.
- [F6]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.20 to $1.23 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range.
- [F7]Represents securities owned directly by CL Trust. Mr. Ravich, as the trustee of CL Trust, may be deemed to beneficially own the securities owned directly by CL Trust.
- [F8]Represents securities owned directly by Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"). Mr. Ravich, as the trustee of ACR Trust, may be deemed to beneficially own the securities owned directly by ACR Trust.
- [F9]Represents securities owned directly by Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust"). Mr. Ravich, as the trustee of ADR Trust, may be deemed to beneficially own the securities owned directly by ADR Trust.
Documents
Issuer
ROCKWELL MEDICAL, INC.
CIK 0001041024
Entity typeother
Related Parties
1- filerCIK 0000897727
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 7:07 PM ET
- Size
- 17.4 KB